BioHealth News Archive
MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients
Prime Medicine to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to advance their innovative Prime Editing technology and develop a new class of…
Read More
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development…
Read More
Charlottesville’s RIVANNA receives $30.5 million from BARDA to advance the Accuro XV musculoskeletal imaging system
CHARLOTTESVILLE, VA, JULY 26, 2023 — RIVANNA®, developers of imaging-based medical solutions, announced that they have received funding totaling $30.5 million over 39 months…
Read More
miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases
After the race to find a COVID-19 vaccine, researchers set off to explore other disease areas with similar RNA vehicles. miRecule, a US biotechnology…
Read More
Virginia Workforce Award to AMPEL BioSolutions
Virginia officials recognized AMPEL BioSolutions today for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area of precision medicine. The…
Read More
Baltimore’s AsclepiX Therapeutics Raises $10 Million to Advance Clinical Study
Perceptive Advisors leads round to execute study in patients with wet age-related macular degeneration (wet AMD) BALTIMORE, MD, July 26, 2023– AsclepiX Therapeutics, Inc., a…
Read More
Virginia’s Solar Biotech Acquires VC-Backed Digital Biotech Noblegen
NORTON, Va. and PETERBOROUGH, ON, July 25, 2023 /PRNewswire/ - Solar Biotech Inc., a Norton, Virginia-based provider of complete sustainable and scalable biomanufacturing solutions, continues to build out its vertically…
Read More
United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the United States Court of…
Read More
Fierce Biotech: Previous Crab Trap Winner Galen Robotics nets FDA de novo clearance for ENT surgery helper
Galen Robotics has claimed a de novo device clearance from the FDA for its digital surgical assistant, designed to provide a helping hand during…
Read More
Apply Now for the 6th Annual BioHealth Capital Region Investor Conference: Uniting Visionary Entrepreneurs and Pioneering Investors for Transformative Funding
The 6th Annual BioHealth Capital Region Investor Conference is just around the corner! Taking place on September 21st, 2023, at the US Pharmacopeia, this…
Read More
FinaBio’s Andrew Lees Wins Derek Horton Award in Industrial Carbohydrate Chemistry
Andrew Lees has received The Derek Horton Award in Industrial Carbohydrate Chemistry for outstanding contributions to industrial carbohydrate chemistry. The Derek Horton Award in…
Read More
Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use Authorization status, and will continue to…
Read More
TEDCO Announces FY24 Board of Directors
Talented, diverse, and experienced leaders tapped to support Maryland’s economic engine for technology companies COLUMBIA, Md. (July 20, 2023) – TEDCO, Maryland’s economic…
Read More
Baltimore’s Vita Therapeutics Collaborates with MilliporeSigma to Advance Preclinical Program for Vita’s Preclinical Cell Therapy for Limb-Girdle Muscular Dystrophy (LGMD2A)
Licensing agreement utilizing MilliporeSigma’s CRISPR genome-editing technology supports the advancement of Vita’s pipelineBaltimore, MD, July 18, 2023 – Vita Therapeutics, Inc. today announced a…
Read More
Introducing the NCI Small Business Transition Grant: A Pathway for Academic Scientists to Entrepreneurship
The Small Business Transition Grant application period is now open, providing a valuable opportunity for early-career academic scientists to transition into entrepreneurship. Graduating students…
Read More